Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. microbiol ; 49(1): 184-188, Jan.-Mar. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-889206

RESUMEN

ABSTRACT Removal of bacterial biofilm from the root canal system is essential for the management of endodontic disease. Here we evaluated the antibacterial effect of N-acetylcysteine (NAC), a potent antioxidant and mucolytic agent, against mature multispecies endodontic biofilms consisting of Actinomyces naeslundii, Lactobacillus salivarius, Streptococcus mutans and Enterococcus faecalis on sterile human dentin blocks. The biofilms were exposed to NAC (25, 50 and 100 mg/mL), saturated calcium hydroxide or 2% chlorhexidine solution for 7 days, then examined by scanning electron microscopy. The biofilm viability was measured by viable cell counts and ATP-bioluminescence assay. NAC showed greater efficacy in biofilm cell removal and killing than the other root canal medicaments. Furthermore, 100 mg/mL NAC disrupted the mature multispecies endodontic biofilms completely. These results demonstrate the potential use of NAC in root canal treatment.


Asunto(s)
Humanos , Acetilcisteína/farmacología , Streptococcus mutans/efectos de los fármacos , Actinomyces/efectos de los fármacos , Enterococcus faecalis/efectos de los fármacos , Biopelículas/efectos de los fármacos , Enfermedades de la Pulpa Dental/microbiología , Ligilactobacillus salivarius/efectos de los fármacos , Antibacterianos/farmacología , Streptococcus mutans/fisiología , Actinomyces/fisiología , Hidróxido de Calcio/farmacología , Clorhexidina/farmacología , Enterococcus faecalis/fisiología , Cavidad Pulpar/microbiología , Viabilidad Microbiana/efectos de los fármacos , Ligilactobacillus salivarius/fisiología
2.
Braz. j. microbiol ; 48(1): 5-6, Jan.-Mar. 2017.
Artículo en Inglés | LILACS | ID: biblio-839345

RESUMEN

Abstract Prevotella intermedia has long been known to be as the principal etiologic agent of periodontal diseases and associated with various systemic diseases. Previous studies showed that the intra-species difference exists in capacity of biofilm formation, antibiotic resistance, and serological reaction among P. intermedia strains. Here we report the genome sequence of P. intermedia SUNY aB G8-9K-3 (designated ATCC49046) that displays a relatively high antimicrobial resistant and biofilm-forming capacity. Genome sequencing information provides important clues in understanding the genetic bases of phenotypic differences among P. intermedia strains.


Asunto(s)
Genoma Bacteriano , Prevotella intermedia/efectos de los fármacos , Prevotella intermedia/fisiología , Biopelículas , Farmacorresistencia Bacteriana , Secuenciación de Nucleótidos de Alto Rendimiento , Antibacterianos/farmacología , Análisis de Secuencia de ADN , Biología Computacional/métodos , Polimorfismo de Nucleótido Simple , Genómica/métodos , Anotación de Secuencia Molecular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA